EUVIMEDEUVIMED entdecken
Leserbrief

Scalable System-Wide CYP2C19 Pharmacogenomic Testing Reveals 38% Excess Incidence of Adverse Events in Metabolizers Receiving Inappropriate Prescriptions

Natalie Telis iD, Douglas Stoller iD, Christopher N Chapman, C Anwar A Chahal iD, Daniel P Judge iD, Douglas A Olson, Joseph J Grzymski iD, Catherine Hajek iD, Teresa Kruisselbrink iD, Nicole L Washington iD, Elizabeth T Cirulli iD

Circulation: Genomic and Precision Medicine · 2026-06 · 19 (3)

DOI: 10.1161/circgen.125.005363 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Circulation: Genomic and Precision Medicine, 2026-06. Verfasst von Natalie Telis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Helix, San Mateo, CA (N.T., C.H., T.K., N.L.W., E.T.C.). Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

drug interactionsexomegenotypeheart failureincidence

Autor:innen und Institutionen

  • Helix, San Mateo, CA (N.T., C.H., T.K., N.L.W., E.T.C.).
  • University of Nebraska Medical Center, Omaha, NE (D.S.).
  • Department of Pathology and Laboratory Medicine, St. Luke's University Health Network, Bethlehem, PA (C.N.C.).
  • Center for Inherited Cardiovascular Diseases, WellSpan Health, Ephrata, PA (C.A.A.C.).
  • Division of Cardiology, Medical University of South Carolina, Charleston (D.P.J.).
  • HealthPartners, Minneapolis, MN (D.A.O.).

ORCID-Profile: Natalie Telis, Douglas Stoller, C Anwar A Chahal, Daniel P Judge, Joseph J Grzymski, Catherine Hajek, Teresa Kruisselbrink, Nicole L Washington, Elizabeth T Cirulli

Zitieren

APA

Telis, N., Stoller, D., Chapman, C. N., Chahal, C. A. A., Judge, D. P., Olson, D. A., Grzymski, J. J., Hajek, C., Kruisselbrink, T., Washington, N. L., & Cirulli, E. T. (2026). Scalable System-Wide CYP2C19 Pharmacogenomic Testing Reveals 38% Excess Incidence of Adverse Events in Metabolizers Receiving Inappropriate Prescriptions. Circulation: Genomic and Precision Medicine, 19(3). https://doi.org/10.1161/circgen.125.005363

Vancouver

Telis N, Stoller D, Chapman CN, Chahal CAA, Judge DP, Olson DA, et al. Scalable System-Wide CYP2C19 Pharmacogenomic Testing Reveals 38% Excess Incidence of Adverse Events in Metabolizers Receiving Inappropriate Prescriptions. Circulation: Genomic and Precision Medicine. 2026;19(3). doi:10.1161/circgen.125.005363

BibTeX
@article{Telis2026,
  author = {Telis, Natalie and Stoller, Douglas and Chapman, Christopher N and Chahal, C Anwar A and Judge, Daniel P and Olson, Douglas A and Grzymski, Joseph J and Hajek, Catherine and Kruisselbrink, Teresa and Washington, Nicole L and Cirulli, Elizabeth T},
  title = {Scalable System-Wide CYP2C19 Pharmacogenomic Testing Reveals 38% Excess Incidence of Adverse Events in Metabolizers Receiving Inappropriate Prescriptions},
  journal = {Circulation: Genomic and Precision Medicine},
  year = {2026},
  volume = {19},
  number = {3},
  doi = {10.1161/circgen.125.005363}
}
Kostenlos starten →